XT
RKDA icon

XTX Topco’s Arcadia Biosciences RKDA Stock Holding History

XTX Topco’s Portfolio RKDA Stock Details RKDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.5K Buy
+15,475
New +$16K ﹤0.01% 4019
2022
Q2 		– Sell
-310
Closed -$17K – 1069
2022
Q1 		$17K Buy
+310
New +$14.8K 0.01% 632

Other funds holding RKDA

HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
SG
StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BWM
Bullock Wealth Management Bloomington, Indiana $231M AUM
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

XTX Topco's RKDA Position: Q2 2026 in Review

XTX Topco opened a new position in Arcadia Biosciences (RKDA) in Q2 2026: 15,475 shares worth $10.5K. The stake represents ﹤0.01% of the portfolio and ranks #4019 among its holdings. This is a return to the name: XTX Topco previously reported a position in RKDA as recently as Q1 2022.

XTX Topco first reported a position in RKDA in Q1 2022 and has held it in 2 quarters since. The position peaked at $17K in Q1 2022. 18 funds tracked by Wall St. Rank hold RKDA as of Q2 2026.

  • XTX Topco held 15,475 shares of Arcadia Biosciences worth $10.5K as of Q2 2026.
  • Arcadia Biosciences was a new XTX Topco position in Q2 2026.
  • Arcadia Biosciences made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #4019 holding.
  • XTX Topco first reported a position in Arcadia Biosciences in Q1 2022 and has held it in 2 quarters since.
  • XTX Topco's Arcadia Biosciences position peaked at $17K in Q1 2022.
  • 18 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.